Related references
Note: Only part of the references are listed.Antisense oligonucleotide therapeutics in neurodegenerative diseases: the case of polyglutamine disorders
Ana C. Silva et al.
BRAIN (2020)
Unveiling synapse pathology in spinal bulbar muscular atrophy by genome-wide transcriptome analysis of purified motor neurons derived from disease specific iPSCs
Kazunari Onodera et al.
MOLECULAR BRAIN (2020)
Truncation of mutant huntingtin in knock-in mice demonstrates exon1 huntingtin is a key pathogenic form
Huiming Yang et al.
NATURE COMMUNICATIONS (2020)
Recent advances in molecular therapies for neurological disease: triplet repeat disorders
Pedro Gonzalez-Alegre
HUMAN MOLECULAR GENETICS (2019)
Suppression of Mutant Protein Expression in SCA3 and SCA1 Mice Using a CAG Repeat-Targeting Antisense Oligonucleotide
Eleni Kourkouta et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2019)
Src inhibition attenuates polyglutamine-mediated neuromuscular degeneration in spinal and bulbar muscular atrophy
Madoka Iida et al.
NATURE COMMUNICATIONS (2019)
Polyglutamine Repeats in Neurodegenerative Diseases
Andrew P. Lieberman et al.
Annual Review of Pathology-Mechanisms of Disease (2018)
Therapies targeting DNA and RNA in Huntington's disease (vol 16, pg 837, 2017)
E. J. Wild et al.
LANCET NEUROLOGY (2017)
Lipid Nanoparticle Systems for Enabling Gene Therapies
Pieter R. Cullis et al.
MOLECULAR THERAPY (2017)
Systemic delivery of factor IX messenger RNA for protein replacement therapy
Suvasini Ramaswamy et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Polyethylenimine Nanoparticle-Mediated siRNA Delivery to Reduce α-Synuclein Expression in a Model of Parkinson's Disease
Christin Helmschrodt et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2017)
The expanded CAG repeat in the huntingtin gene as target for therapeutic RNA modulation throughout the HD mouse brain
Nicole A. Datson et al.
PLOS ONE (2017)
Therapies targeting DNA and RNA in Huntington's disease
Edward J. Wild et al.
LANCET NEUROLOGY (2017)
Targeting CAG repeat RNAs reduces Huntington's disease phenotype independently of huntingtin levels
Laura Rue et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Silencing neuronal mutant androgen receptor in a mouse model of spinal and bulbar muscular atrophy
Kentaro Sahashi et al.
HUMAN MOLECULAR GENETICS (2015)
Allele-selective suppression of mutant genes in polyglutamine diseases
Chia-Rung Liu et al.
JOURNAL OF NEUROGENETICS (2015)
Intraventricular Delivery of siRNA Nanoparticles to the Central Nervous System
Rishab Shyam et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2015)
Allele-Selective Inhibition of Mutant Atrophin-1 Expression by Duplex and Single-Stranded RNAs
Jiaxin Hu et al.
BIOCHEMISTRY (2014)
Phosphorodiamidate morpholino oligomers suppress mutant huntingtin expression and attenuate neurotoxicity
Xin Sun et al.
HUMAN MOLECULAR GENETICS (2014)
Muscle Expression of Mutant Androgen Receptor Accounts for Systemic and Motor Neuron Disease Phenotypes in Spinal and Bulbar Muscular Atrophy
Constanza J. Cortes et al.
NEURON (2014)
Oligonucleotide-based strategies to combat polyglutamine diseases
Agnieszka Fiszer et al.
NUCLEIC ACIDS RESEARCH (2014)
Peripheral Androgen Receptor Gene Suppression Rescues Disease in Mouse Models of Spinal and Bulbar Muscular Atrophy
Andrew P. Lieberman et al.
CELL REPORTS (2014)
Allele-Selective Inhibition of Expression of Huntingtin and Ataxin-3 by RNA Duplexes Containing Unlocked Nucleic Acid Substitutions
Yuichiro Aiba et al.
BIOCHEMISTRY (2013)
RNA duplexes with abasic substitutions are potent and allele-selective inhibitors of huntingtin and ataxin-3 expression
Jing Liu et al.
NUCLEIC ACIDS RESEARCH (2013)
5′ Unlocked Nucleic Acid Modification Improves siRNA Targeting
Nicholas M. Snead et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2013)
Lipid Nanoparticle Delivery of siRNA to Silence Neuronal Gene Expression in the Brain
Ravi L. Rungta et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2013)
TSUNAMI: an antisense method to phenocopy splicing-associated diseases in animals
Kentaro Sahashi et al.
GENES & DEVELOPMENT (2012)
Mechanism of allele-selective inhibition of huntingtin expression by duplex RNAs that target CAG repeats: function through the RNAi pathway
Jiaxin Hu et al.
NUCLEIC ACIDS RESEARCH (2012)
Pathogenesis and therapy of spinal and bulbar muscular atrophy (SBMA)
Masahisa Katsuno et al.
PROGRESS IN NEUROBIOLOGY (2012)
Inhibition of mutant huntingtin expression by RNA duplex targeting expanded CAG repeats
Agnieszka Fiszer et al.
NUCLEIC ACIDS RESEARCH (2011)
Allele-Selective Inhibition of Mutant Huntingtin Expression with Antisense Oligonucleotides Targeting the Expanded CAG Repeat
Keith T. Gagnon et al.
BIOCHEMISTRY (2010)
Allele-Selective Inhibition of Huntingtin Expression by Switching to an miRNA-like RNAi Mechanism
Jiaxin Hu et al.
CHEMISTRY & BIOLOGY (2010)
Targeted Delivery of RNAi Therapeutics With Endogenous and Exogenous Ligand-Based Mechanisms
Akin Akinc et al.
MOLECULAR THERAPY (2010)
UNA (unlocked nucleic acid): A flexible RNA mimic that allows engineering of nucleic acid duplex stability
Niels Langkjaer et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2009)
Allele-specific silencing of mutant huntingtin and ataxin-3 genes by targeting expanded CAG repeats in mRNAs
Jiaxin Hu et al.
NATURE BIOTECHNOLOGY (2009)
CAG repeat lengths >= 335 attenuate the phenotype in the R6/2 Huntington's disease transgenic mouse
I. Dragatsis et al.
NEUROBIOLOGY OF DISEASE (2009)
Accumulation of N-terminal mutant huntingtin in mouse and monkey models implicated as a pathogenic mechanism in Huntington's disease
Chuan-En Wang et al.
HUMAN MOLECULAR GENETICS (2008)
Insights into the kinetics of siRNA-mediated gene silencing from live-cell and live-animal bioluminescent imaging
DW Bartlett et al.
NUCLEIC ACIDS RESEARCH (2006)
Long-lasting RNAi activity in mammalian neurons
K Omi et al.
FEBS LETTERS (2004)
Testosterone reduction prevents phenotypic expression in a transgenic mouse model of spinal and bulbar muscular atrophy
M Katsuno et al.
NEURON (2002)
Share Paper
